Related Experiment Videos
[Treatment of purulent meningitis in childhood]
J P Guggenbichler1, F Allerberger, O Dietze
1Universitäts-Kinderklinik, Innsbruck.
Abstract:
Treatment of bacterial meningitis in children requires the choice of the optimal antimicrobial substance: besides the in vitro susceptibility also pharmacokinetic parameters (CSF penetration and elimination) have to be considered. A careful medical history and a few laboratory tests (gram-stain and antigen determination) provide a preliminary bacterial diagnosis within less than one hour. In addition to the identification of the causative organism also the determination of the number of colony forming units per milliliter CSF is of crucial importance. A rapid bacterial cell kill of high numbers of pneumococci, meningococci and streptococci group B overwhelms the CSF with endotoxins with rapidly increasing cerebral edema. Applying a slowly increasing dosage regimen proved effective in preventing this detrimental effects. Supportive therapy e.g. treatment of septic shock, disseminated intravascular coagulation, cerebral edema and anticonvulsive therapy is of paramount importance. Inadequate ADH secretion in the majority of patients requires a restricted fluid and electrolyte supplementation. By this combined therapeutic approach a remarkable low lethality rate and a low number of patients with late sequelae was seen.
Insights
Optimizing antimicrobial therapy for pediatric bacterial meningitis involves considering pharmacokinetics and rapid bacterial diagnosis. A slow-dosage regimen and supportive care reduce mortality and long-term complications.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Pharmacology
- Microbiology
Context:
- Bacterial meningitis in children necessitates careful antimicrobial selection.
- Pharmacokinetic parameters, including cerebrospinal fluid (CSF) penetration and elimination, are critical alongside in vitro susceptibility.
- Rapid preliminary diagnosis (under 1 hour) via Gram stain and antigen determination aids timely treatment.
Purpose:
- To outline an optimal therapeutic strategy for pediatric bacterial meningitis.
- To emphasize the importance of pharmacokinetic considerations and rapid diagnostics.
- To highlight the role of supportive care and fluid management in improving outcomes.
Summary:
- Effective treatment requires balancing antimicrobial efficacy with CSF pharmacokinetics.
- Rapid identification of causative agents and bacterial load is crucial for predicting endotoxin release.
- A slowly increasing dosage regimen prevents detrimental effects from rapid bacterial lysis.
- Supportive therapies for septic shock, DIC, cerebral edema, and seizures are vital.
- Restricted fluid and electrolyte management addresses inadequate ADH secretion.
Impact:
- This combined approach significantly lowers lethality rates in pediatric bacterial meningitis.
- It also reduces the incidence of late sequelae in affected children.
- Optimized treatment strategies improve patient prognosis and long-term health outcomes.